🔎 Trials Near Me

ホーム › 転移性癌 › インディアナ州

インディアナ州における転移性癌の臨床試験

インディアナ州内の拠点で、転移性癌に関する25件の研究が参加者を募集しています。

インディアナ州内の都市

公式研究テキスト(英語)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • UChicago Medicine Northwest Indiana, Crown Point
  • Woodland Cancer Care Center, Michigan City
被験者募集中第2相
全年齢 · 全性別 · 2026/10/02更新 · NCT05564377

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • IU Simon Cancer Center, Indianapolis
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06465069

A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

  • Research Site, Fort Wayne
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07205822

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

  • Indiana University Simon Comprehensive Cancer Center, Indianapolis
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06625775

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  • Franciscan Health, Indianapolis
  • Franciscan Health Mooresville, Mooresville
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07222800

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  • Community Health Network, Inc, Indianapolis
  • Community Health Network, Inc., Indianapolis
  • Community Health Network, Inc., Indianapolis
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07222566

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  • Parkview Research Center at Parkview Regional Medical Center, Fort Wayne
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
  • Franciscan Health, Indianapolis
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • Indiana University Health University Hospital, Indianapolis
  • Deaconess GI Specialty Center, Newburgh
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07174336

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Community Health Network, Indianapolis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
  • Franciscan Health, Indianapolis
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213804

AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors

  • Community Health Network MD Anderson Cancer Center - North, Indianapolis
被験者募集中第1相
18歳〜99歳 · 全性別 · 2026/09/21更新 · NCT07403721

Prospective Validation of a Points Score System Predicting 30-day Survival

  • IU Health West, Avon
  • IU Health North / Schwarz Cancer Center, Carmel
  • Methodist Hospital, Indianapolis
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/17更新 · NCT05100342

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Parkview Research Center at Parkview Regional Medical Center, Fort Wayne
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
  • Franciscan Health, Indianapolis
  • 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581

A Study of IDP-001 in Advanced or Metastatic Solid Tumors

  • Community Cancer Center North, Indianapolis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/03更新 · NCT07602842

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

  • Northwest Cancer Center, Dyer
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/02更新 · NCT06072612

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

  • Indiana University (IU) Melvin and Bren Simon Cancer Center, Indianapolis
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/20更新 · NCT05614739

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  • Community Health Network, Indianapolis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/30更新 · NCT04657068

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

  • Research Site, Fort Wayne
  • Research Site, Indianapolis
被験者募集中第3相
18歳以上 · 女性 · 2026/07/29更新 · NCT07044336

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

  • Parkview Packnett Family Cancer Institute, Fort Wayne
  • Franciscan Health Indianapolis, Indianapolis
被験者募集中第3相
18歳以上 · 全性別 · 2026/06/25更新 · NCT06216301

A Study of LY4175408 in Participants With Advanced Cancer

  • Community Health Network, Indianapolis
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/23更新 · NCT07046923

Evaluating Disparities in Precision Oncology

  • Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
被験者募集中観察研究
18歳以上 · 全性別 · 2026/06/16更新 · NCT06081517

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

  • Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
被験者募集中第2/3相
18歳以上 · 男性 · 2026/04/08更新 · NCT04787744

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

  • Fort Wayne Medical Oncology and Hematology, Fort Wayne
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/01更新 · NCT05735080

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

  • Northwest Cancer Centers, Dyer
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/03/18更新 · NCT06244771

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

  • First Urology, Jeffersonville
被験者募集中第1相
18歳以上 · 男性 · 2026/02/04更新 · NCT04729114

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。